Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,121.50
18.30 (0.87%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹35.94K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
34.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹2,088.1+1.6%
52W High₹3,413.1-37.8%
Current Price
₹2,121.50
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,697.20
Upper Circuit₹2,545.80
Reference Price
₹2,121.50
Investment Checklist
Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹1745.9
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹2433.7
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -44.55 (SELL) with 81.7% confidence
Unusual volume detected (2.9x average) — institutional activity likely
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
82%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
2211.86
EMA50
2275.63
EMA200
2488.58
Price Action
DOWNTREND
BEARISH
Higher Highs2
Higher Lows2
Lower Highs7
Lower Lows7
Support & Resistance Levels
Resistance (Above)
₹2163.47
₹2261.80
₹2304.00
₹2343.40
₹2407.07
Support (Below)
No recent support detected
Volume Analysis
TrendDECREASING
Change-14.10%
Unusual Volume
Yes (2.93x avg)
Stop Loss Levels
Fixed Risk
1% Risk₹2100.28
3% Risk₹2057.86
5% Risk₹2015.42
7% Risk (Custom)
₹1972.99Technical Levels
1x ATR (Volatility)₹2070.53
2x ATR (Swing)₹2019.56
3x ATR (Trend)₹1968.59
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹949.4 Cr | ₹951.2 Cr | ₹805.2 Cr | ₹1,041.3 Cr |
| Net Profit | ₹229.9 Cr | ₹262.9 Cr | ₹205 Cr | ₹295.6 Cr |
| EPS | ₹13.57 | — | ₹12.10 | ₹17.45 |
| Operating Profit | ₹327 Cr | ₹373.9 Cr | ₹294.9 Cr | ₹421.4 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Dividend - Rs 57 Per Share | DIVIDEND |
| 30 May 2025 | Dividend - Rs 42 Per Share | DIVIDEND |
| 07 Nov 2024 | Interim Dividend - Rs 12 Per Share | INTERIM_DIVIDEND |
| 31 May 2024 | Dividend - Rs 32 Per Share | DIVIDEND |
| 30 Jun 2023 | Dividend - Rs 32 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for GLAXO
View All
positive
NDTV Profit 17d ago
Bajaj Auto, Bank Of India, Glaxo, ICICI Lombard, Torrent Pharma, Uno Minda: Dividend Record Date: Last Day To Buy Shares To Qualify
Dividend Record Date: Last Day To Buy Shares To Qualify
AUTOIETFBAJAJ-AUTOBANKBETFBANKIETFBANKINDIADIVIDENDFINIETFGLAXOICICIBANKICICIGIMINDACORPPSUBNKIETFPVTBANIETFUNOMINDAAutomobile and Auto ComponentsFinancial Services
negative
ET Markets - Industry 25d ago
GSK's Calpol a well-known trademark: High Court
The Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This designation acknowledges Calpol's extensive recognition in India since 1991. The court found that consumers associate the brand exclusively with GSK due to its long and continuous use.
GLAXOHealthcare
NEWS
positive
Business Standard - Markets 30d ago
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
Glaxosmithkline Pharmaceuticals rose 1.65% to Rs 2,446.60 after its standalone net profit jumped 5.68% to Rs 274.94 crore on 2.38% increase in revenue from operations to Rs 989.15 crore in Q4 FY26 over Q4 FY25.
GLAXOHealthcare